姓名：劉福生   性別：男   職稱(chēng)：教授

招生類(lèi)型：科學(xué)與專(zhuān)業(yè)學(xué)位(碩) 科學(xué)與專(zhuān)業(yè)學(xué)位(博)

招生專(zhuān)業(yè)：外科學(xué)（神外）(碩) 外科學(xué)（神外）(博)

研究方向：膠質(zhì)瘤的基礎(chǔ)和臨床

電子信箱：liufushengs@hotmail.com

社會(huì)任職

1. 《中華診斷學(xué)電子雜志》 編委

2. 生物醫(yī)學(xué)材料-北京實(shí)驗(yàn)室 專(zhuān)家委員會(huì)委員

3. 北京市衛(wèi)生系統(tǒng)高層次衛(wèi)生技術(shù)人才 神經(jīng)外科學(xué)科帶頭人

4. 《中華腦科疾病與康復(fù)雜志（電子版）》審稿專(zhuān)家

5. 《中華臨床醫(yī)師雜志（電子版）》 特邀審稿專(zhuān)家

6. 《中華臨床醫(yī)師雜志（電子版）》 編委

7. 《藥品評(píng)價(jià)》常務(wù)編委

個(gè)人簡(jiǎn)歷

1. 200411-      :北京市神經(jīng)外科研究所腦腫瘤研究中心及首都醫(yī)科大學(xué)附屬北京天壇醫(yī)院神外六病房 腦腫瘤研究中心主任；教授、主任醫(yī)師、 研究員

2. 200205-200411:美國(guó)國(guó)立衛(wèi)生研究院（National Institutes of Health,NIH) 博士后

3. 200107-200205:北京市神經(jīng)外科研究所及首都醫(yī)科大學(xué)附屬北京天壇醫(yī)院神外 副研究員

4. 199909-200107:首都醫(yī)科大學(xué)臨床醫(yī)學(xué)博士后流動(dòng)站 博士后

5. 199609-199907:山東醫(yī)科大學(xué)神經(jīng)外科博士學(xué)位研究生 獲博士學(xué)位

6. 199307-199608:濰坊醫(yī)學(xué)院附屬醫(yī)院神經(jīng)外科 主治醫(yī)師

7. 199009-199307:山東醫(yī)科大學(xué)神經(jīng)外科碩士學(xué)位研究生 獲碩士學(xué)位

8. 198707-199009:濰坊市益都中心醫(yī)院 住院醫(yī)師

9. 198209-198707:濰坊醫(yī)學(xué)院醫(yī)療系 學(xué)生，獲學(xué)士學(xué)位

重要學(xué)術(shù)論文

1. Zhang Q, Wang Y, Liu F*.Cancer-associated fibroblasts: Versatile mediators in remodeling the tumor microenvironment.Cell Signal.2023.103.110567.SCI

2. Wang P, Zhang J, Zhang Q, Liu F *.Mesenchymal stem cells loaded with Ad5-Ki67/IL-15 enhance oncolytic adenovirotherapy in experimental glioblastoma.Biomed Pharmacother.2023.157.114035.SCI

3. Liu SS, Li MX, Sun FQ, Zhang JW, Liu FS *.Enhancing the immune effect of oHSV-1 therapy through TLR3 signaling in uveal melanoma.J Cancer Res Clin.2023.149(2).901-912.SCI

4. Zhang JW, Wang JL, Li M, Su XD, Tian YF, Wang PW, Zhou XZ, Jin GS, Liu FS *.Oncolytic HSV-1 suppresses cell invasion through downregulating Sp1 in experimental glioblastoma.Cell Signal.2023.103.110581.SCI

5. Su X, Xie Y, Zhang J, Li M, Zhang Q, Jin G, Liu F*.HIF-alpha activation by the prolyl hydroxylase inhibitor roxadustat suppresses chemoresistant glioblastoma growth by inducing ferroptosis.Cell Death Dis.2022.13(1).861.SCI

6. Zhang Q, Zhang J, Wang P, Zhu G, Jin G, Liu F *.Glioma-associated mesenchymal stem cells-mediated PD-L1 expression is attenuated by Ad5-Ki67/IL-15 in GBM treatment.Stem cell research & therapy.2022.13(1).284.SCI

7. Guidong Zhu, Junwen Zhang, Qing Zhang, Guishan Jin, Xiaodong Su, Sisi Liu, Fusheng Liu*.Enhancement of CD70?specific CAR T treatment by IFN?γ released from oHSV?1?infected glioblastoma.Cancer Immunology, Immunotherapy.2022.71(10).2433-2448.SCI

8. Ruifang Mi, Jiayu Ji, Mengmeng Zhang, Junwen Zhang, Mingxin Li, Yuedong Hu, Fusheng Liu*.Establishment of the glioma polyploid giant cancer cell model by a modified PHA-DMSO-PEG fusion method following dual drug-fluorescence screening in vitro.Journal of Neuroscience Methods.2022.368.109462.SCI

9. Xiangming Han, Qiyan Wang, Sheng Fang, Jialin Wang, Fusheng Liu, Junwen Zhang* and Guishan Jin*.P4HA1 regulates CD31 via COL6A1 in the transition of glioblastoma stem-like cells to tumor endothelioid cells.Frontiers in Oncology.2022.12.836511.SCI

10. Sisi Liu, Junwen Zhang, Sheng Fang, Qing Zhang, Guidong Zhu, Yifu Tian, Mingwei Zhao*, Fusheng Liu*.Macrophage polarization contributes to the efficacy of an oncolytic HSV-1 targeting human uveal melanoma in a murine xenograft model.Experimental EyeResearch.2021.202.108285.SCI

11. Chengyuan Dong, Sheng Hong, Diwei Zheng, Qianxiao Huang, Fusheng Liu*, Zhenlin Zhong*, Xianzheng Zhang*.Multifunctionalized Gold Sub-Nanometer Particles for Sensitizing Radiotherapy against Glioblastoma.Small.2021.17.e2006582.SCI

12. Zhu G, Zhang Q, Zhang J, Liu F*.Targeting Tumor-Associated Antigen: A Promising CAR-T Therapeutic Strategy for Glioblastoma Treatment.Front Pharmacol.2021.12.661606.SCI

13. Wang Q, Zhang J, Fang S, Wang J, Han X, Liu F*, Jin G*.P4HA1 Down-Regulation Inhibits Glioma Invasiveness by Promoting M1 Microglia Polarization.Onco Targets Ther.2021.14.1771-1782.SCI

14. 季佳宇，王啟儼，方勝，田毅夫，劉福生，米蕊芳*.EA-IL-15溶瘤腺病毒的構(gòu)建及其對(duì)膠質(zhì)瘤細(xì)胞特異性及有效性研究.醫(yī)學(xué)研究雜志.2020.49（10）.47-51.核心期刊

15. 張夢(mèng)夢(mèng)，張俊文，米蕊芳，金貴善，劉福生*.siRNA干擾BTN3A3對(duì)腦膠質(zhì)瘤細(xì)胞凋亡作用的研究.中華神經(jīng)外科雜志.2020.36（9）.951-956.核心期刊

16. 方勝, 張俊文, 董程遠(yuǎn), 田毅夫, 王啟儼, 劉福生, 金貴善*.P4HA1調(diào)控EMT影響腦膠質(zhì)瘤侵襲性研究.中國(guó)科學(xué): 生命科學(xué).2020.50（4）.446-457.核心期刊

17. Qing Zhang, Junwen Zhang, Yifu Tian, Guidong Zhu, Sisi Liu and Fusheng Liu*.Efficacy of a novel double-controlled oncolytic adenovirus driven by the Ki67 core promoter and armed with IL-15 against glioblastoma cell.Cell Bioscience.2020.10.124（1-12）.SCI

18. Shiqi Hu#, Chengyuan Dong#, Jinqiang Wang, Kexin Liu, Quan Zhou, Jiajia Xiang, Zhuxian Zhoua*, Fusheng Liu*, Youqing Shen*.Assemblies of indocyanine green and chemotherapeutic drug to cure established tumors by synergistic chemo-photo therapy.Journal of Controlled Release.2020.324.250-259.SCI

19. Sisi Liu, Junwen Zhang, Sheng Fang, Xiaodong Su, Qing Zhang, Guidong Zhu, Li Zhu, Mingwei Zhao*, Fusheng Liu*.Antitumor efficacy of oncolytic HSV-1 expressing cytosine deaminase is synergistically enhanced by DPD down-regulation and EMT inhibition in uveal melanoma xenograft.Cancer Letters.2020.495.123-134.SCI

20. Qing Zhang and Fusheng Liu*.Advances and potential pitfalls of oncolytic viruses expressing immunomodulatory transgene therapy for malignant gliomas.Cell Death & Disease.2020.11:485.1-11.SCI

21. Junwen Zhang#, Sheng Fang#, Wenjie Song, Bo Zhang, Wenhua Fan, Guishan Jin, Fusheng Liu*.Biological Characterization and Therapeutics for Subscalp Recurrent in Intracranial Glioblastoma.OncoTargets and Therapy.2020.13.9085-9099.SCI

22. Ruifang Mi, Wenhua Fan, Jiayu Ji, Chengyuan Dong, Guishan Jin, Fusheng Liu*.The enhanced efficacy of herpes simplex virus by lentivirus mediated VP22 and cytosine deaminase gene therapy against glioma.Brain Research.2020.1743.146898（1-9）.SCI

23. Sisi Liu, Fusheng Liu, Mingwei Zhao, Junwen Zhang*.Antitumor efficacy of Oncolytic herpes virus type I armed with GM-CSF in murine uveal melanoma xenografts.Cancer Management and Research.2020.12.1-10.SCI

24. 張夢(mèng)夢(mèng)，蘇曉東，田毅夫，季佳宇，劉福生*.BTN3A3低表達(dá)促進(jìn)肝細(xì)胞癌的惡性進(jìn)展.醫(yī)學(xué)研究雜志.2020.49（4）.75-80.核心期刊

25. Yiqiang Zhou, Yang Liu, Junwen Zhang, Di Yu, Aiguo Li, Hua Song, Wei Zhang, Dionne Davis, Mark R. Gilbert, Fusheng Liu*, and Chunzhang Yang*.Autocrine BMP4 Signaling Enhances Tumor Aggressiveness via Promoting Wnt/β-Catenin Signaling in IDH1-mutant Gliomas.Translational Oncology.2020.13（2）.125-134.SCI

26. Quan Zhou, Chengyuan Dong, Wufa Fan, Haiping Jiang, Jiajia Xiang, Nasha Qiu,Ying Piao, Tao Xie, Yingwu Luo, Zichen Li, Fusheng Liu, Youqing Shen?.Tumor extravasation and infiltration as barriers of nanomedicine for high efficacy: The current status and transcytosis strategy.Biomaterials.2020.240.119902.SCI

27. Fan-Wei Meng, Fu-Sheng Liu, Wen-Hui Liu, Li Li and Lin-Lin Jie.Formation of new lymphatic vessels in glioma: An immunohistochemical analysis.Neuropathology.2020.40(3）.215-223.SCI

28. Chengyuan Dong, Junwen Zhang, Sheng Fang and Fusheng Liu*.IGFBP5 increases cell invasion and inhibits cell proliferation by EMT and Akt signaling pathway in Glioblastoma multiforme cells.Cell Division.2020.15.4.SCI

29. Chengyuan Dong, Quan Zhou, Jiajia Xiang*, Fusheng Liu*, Zhuxian Zhou*, Youqing Shen.Self-assembly of oxidation-responsive polyethylene glycol-paclitaxel prodrug for cancer chemotherapy.Journal of Controlled Release.2020.321.529-539.SCI

30. 張俊文，范文華，方勝，陳虹，黃秉仁，劉福生*.shRNA干擾eIF4A1基因?qū)δz質(zhì)瘤細(xì)胞體內(nèi)外生物學(xué)特征的影響.中國(guó)科學(xué): 生命科學(xué).2019.49.987-995.核心期刊

31. 張俊文，趙喬佳杰，楊霞，馬雯，黃秉仁，劉福生*.RanBPM調(diào)控IFNlR1-STAT5通路分子機(jī)制研究.醫(yī)學(xué)研究雜志.2019.48（8）.31-36.核心期刊

32. Bo Zhang#, Junwen Zhang#, Sheng Fang, Mengmeng Zhang, Sisi Liu, Yifu Tian, Mengjiao Ma, Fusheng Liu, Guishan Jin*. Inflammatory activation of microglia by Staphylococcus aureus caused phenotypic alterations and affected glioblastoma growth.Cell Biochem Funct.2019.1-9.DOI: 10.1002/cbf.3396.SCI

33. Zhang J, Cui B, Chen H, Huang BR*, Liu F*.eIF4A1 is associated with TrkA and inhibits TrkA polyubiquitination.Prog. Biochem, Biophys.2019.46（8）.812-822.SCI

34. Wenhua Fan, Meiyu Shao, Junwen Zhang, Guishan Jin, Fu-Jian Xu,* and Fusheng Liu*.Hybrid nanovector of suicide gene engineered lentivirus coated with bioreducible polyaminoglycosides for enhancing therapeutic efficacy against glioma.Adv. Funct. Mater..2019.29.1807104.SCI

35. 劉福生，李小鵬，田超，張俊文.TSPO在治療腦膠質(zhì)瘤中的應(yīng)用及重組單純皰疹病毒及其制備方法和應(yīng)用。國(guó)家發(fā)明專(zhuān)利，專(zhuān)利號(hào)：ZL 2017 1 1251406.7.中華人民共和國(guó)國(guó)家知識(shí)產(chǎn)權(quán)局.2019. . .

36. 張俊文，劉福生，方勝，宋文杰.一種人腦膠質(zhì)瘤細(xì)胞系及其建立方法和應(yīng)用.國(guó)家發(fā)明專(zhuān)利，專(zhuān)利號(hào)：ZL 2018 1 1535397.9.中華人民共和國(guó)國(guó)家知識(shí)產(chǎn)權(quán)局.2019. . .

37. 張昀昇，張俊文，米蕊芳，周益強(qiáng)，程森，宋文杰，劉福生，金貴善*.TRIM33對(duì)人腦膠質(zhì)瘤U251細(xì)胞生物學(xué)功能影響的實(shí)驗(yàn)研究.中華神經(jīng)外科雜志.2018.34（3）.292-298.核心期刊

38. Sisi Liu #, Wenjie Song #, Fusheng Liu2, Junwen Zhang2*, Siquan Zhu1*.Antitumor efficacy of VP22-CD/5-FC suicide gene system mediated by lentivirus in a murine uveal melanoma model.Experimental Eye Research.2018.172.144-151.SCI

39. Yunsheng Zhang#, Guishan Jin#, Junwen Zhang, Ruifang Mi, Yiqiang Zhou, Wenhua Fan, Sen Cheng, Wenjie Song, Bo Zhang, Mengjiao Ma, Fusheng Liu*.Overexpression of STAT1 suppresses angiogenesis under hypoxia by regulating VEGF?A in human glioma cells.Biomedicine & Pharmacotherapy.2018.104.566-575.SCI

40. 徐恒周，金貴善，米蕊芳，張俊文，周益強(qiáng)，劉福生*.FASN在腦膠質(zhì)瘤組織中的表達(dá)及其臨床意義.中華神經(jīng)醫(yī)學(xué)雜志.2017.16（3）.217-221.核心期刊

41. Liu J, Wang Y, Sun X, Ji N, Sun S, Wang Y, Liu F, Cui Q, Wang C#, Liu Y#.Promoter methylation attenuates SHP1 expression and function in patients with primary central nervous system lymphoma.Oncology reports.2017.37.887-894.SCI

42. JW Zhang XJ Cong, J Zhao, X Yang, M Li, H Chen, FS Liu, *, BR Huang*.Ran bingding protein 9(RanBPM)binds IFN-λR1 in the IFN-λ signaling pathway.Sci China Life Sci.2017.60（9）.1030-1039.SCI

43. Zhou Y, Jin G, Mi R, Zhang J, Zhang J, Xu H, Cheng S, Zhang Y, Song W, Liu F*.Knockdown of P4HA1 inhibits neovascularization via targeting glioma stem cell-endothelial cell transdifferentiation and disrupting vascular basement membrane.Oncotarget.2017.8（22）.35877-35889.SCI

44. Sen Cheng#,Ruifang Mi #, Yu Xu,Guishan Jin,Junwen Zhang, Yiqiang Zhou,Zhengguang Chen, Fusheng Liu*.Ferritin heavy chain as a molecular imaging reporter gene in glioma xenografts.J Cancer Res Clin Oncol .2017.143（6）.941-951.SCI

45. 張俊文，叢曉杰，趙喬佳杰，楊霞，李夢(mèng)，陳虹，米蕊芳，金貴善，黃秉仁，劉福生*.RanBPM結(jié)合干擾素γ信號(hào)通路中的干擾素受體1.中國(guó)科學(xué) 生命科學(xué).2017.47（7）.718-727.核心期刊

46. Guobin Zhang, Yunsheng Zhang, Sen Cheng, Zhen Wu, Fusheng Liu*, Junting Zhang*.CD133 positive U87 glioblastoma cells-derived exosomal microRNAs in hypoxia- versus normoxia-microenviroment.J Neuro-oncol.2017.135.37-46.SCI

47. 張俊文,杜延順,米蕊芳,陳虹,劉福生*,黃秉仁*.TGF-βRI與Fascin1的相互作用..基礎(chǔ)醫(yī)學(xué)與臨床.2016.36（3）.315-319.核心期刊

48. 劉福生，金貴善*.對(duì)醫(yī)學(xué)專(zhuān)業(yè)學(xué)位碩士研究生科研能力培養(yǎng)的思考與體會(huì).醫(yī)學(xué)教育管理.2016.2（2）.438-440.核心期刊

49. 米蕊芳，金貴善，張俊文，周益強(qiáng)，徐恒周，程森，劉福生*.VP22-CD基因工程化載體對(duì)膠質(zhì)瘤細(xì)胞體外殺傷作用的研究.中華神經(jīng)外科雜志.2016.6（32）.614-618.核心期刊

50. Mi RF, Pan CX, Zhou YQ, Liu YB, Jin GS*, Liu FS*.Identification of the metastasis potential and its associated genes in melanoma multinucleated giant cells using the PHA-ECM830 fusion method.Oncology reports.2016.35（1）.211-218.SCI

51. Zhou Y, Jin G, Mi R, Zhang J, Zhang J, Xu H, Cheng S, Zhang Y, Song W, Liu F*.Inhibition of fatty acid synthase suppresses neovascularization via regulating the expression of VEGF-A in glioma.J Cancer Res Clin Oncol.2016.142.2447-2459.SCI

52. 張俊文，劉福生*.醫(yī)學(xué)基礎(chǔ)學(xué)科研究生科學(xué)實(shí)驗(yàn)與研究能力培養(yǎng)方式探討.醫(yī)學(xué)教育管理.2016.2（supp2）.121-123.核心期刊

53. 金貴善，劉福生*.醫(yī)學(xué)碩士研究生創(chuàng)新能力培養(yǎng)的分析和思考.醫(yī)學(xué)教育管理.2016.2（supp2）.118-120.核心期刊

54. Yang Hu#, Yiqiang Zhou#, Nana Zhao, Fusheng Liu*, and Fu-jiang Xu*.Multifunctional pDNA-conjugated polycationic au nanorod-coated Fe3O4 hierarchical nanocomposites for trimodal imaging and combined photothermal/gene therapy.Small.2016.12(18).2459-2468.SCI

55. Nana Zhao, Jia Li, Yiqiang Zhou, Yang Hu, Ranran Wang, Zhaoxia Ji, Fusheng Liu*, Fujian Xu*. Hierarchical Nanohybrids of Gold Nanorods and PGMA-Based Polycations for Multifunctional Theranostics.Advanced functional materials.2016.26.5848-5861.SCI

56. 張國(guó)濱，張晉，徐恒周，周益強(qiáng)，程森，劉福生*.支鏈氨基酸氨基轉(zhuǎn)移酶1在惡性膠質(zhì)瘤中的表達(dá)及意義.中華神經(jīng)外科雜志.2015.31（12）.1259-1262.核心期刊

57. 張晉，金貴善，米蕊芳，周益強(qiáng)，房紹偉，朱樹(shù)干，劉福生*.腦膠質(zhì)瘤干細(xì)胞內(nèi)皮細(xì)胞分化差異基因表達(dá)譜的分析.中華神經(jīng)外科雜志.2015.31（3）.299-303.核心期刊

58. Dong C#, Mi R#, Jin G, Zhou Y, Zhang J, Liu F*.Identification of the proliferative effect of Smad2 and Smad3 in TGFβ2/Smads signal pathway using RNA interference in glioma cell line.Molecular Medicine Reports.2015.12.1824-1828.SCI

59. Zhao Y, Duan S, Yu B, Liu FS, Cheng G, Xu FJ*.Gd(III) ino-chelated supramolecular assemblies composed of PGMA-based polycations for effective biomedical applications.NPG Asia Materials.2015.7.e197.SCI

60. Zhang GB, Jin GS, Nie XT, Mi RF, Zhu Guidong, Liu FS*.Enhanced antitumor efficacy of an oncolytic herpes simplex virus expressing an endostatin-angiostatin fusion gene in human glioblastomas stem cell xenografts.PLOS ONE.2014.9（4）.e95872.SCI

61. Zhou YQ, Jin GS, Mi RF, Dong CY, Zhang J, Liu FS*.The methylation status of the platelet-derived growth factor-B gene promoter and its regulation of cellular proliferation following folate treatment in human glioma cells.Brain Research.2014.1556.57-66.SCI

62. Yang Hu, Nana Zhao, Bingran Yu, Fusheng Liu*, Fu-Jian Xu*.Versatile types of Polysaccharide-Based Supramolecular Polycation/pDNA Nanoplexes for Gene Delivery.Nanoscale.2014.6（13）.7560-7569.SCI

63. 周益強(qiáng)， 金貴善，劉福生*.PDGF-B在腦膠質(zhì)瘤中的研究進(jìn)展.中華神經(jīng)外科雜志.2014.30（8）.844-846.核心期刊

64. 張國(guó)濱，金貴善，米蕊芳，周益強(qiáng)，董程遠(yuǎn)，劉福生*.內(nèi)皮抑素和血管生成抑素融合基因修飾的單純皰疹病毒對(duì)膠質(zhì)瘤干細(xì)胞殺傷作用的實(shí)驗(yàn)研究.中華神經(jīng)外科雜志 .2014.30（7）.723-728.核心期刊

65. Bin Xu, Dong-Ming Yu*, Fu-Sheng Liu*.Effect of siRNA?induced inhibition of IL?6 expression in rat cerebral gliocytes on cerebral edema following traumatic brain injury.Molecular Medicine Reports.2014.10.1863-1864.SCI

66. 董程遠(yuǎn)，金貴善，米蕊芳，周益強(qiáng)，張晉，劉福生*.shRNA干擾技術(shù)對(duì)腦膠質(zhì)瘤細(xì)胞中TGFβ2/Smads通路的研究.中華神經(jīng)外科雜志.2014.30（4）.404-408.核心期刊

67. 聶秀濤，金貴善，徐厚池，劉福生*.腦膠質(zhì)瘤干細(xì)胞和血管關(guān)系的研究進(jìn)展.中華神經(jīng)外科雜志.2014.30(3).315-317.核心期刊

68. 陳寶師，畢智勇，張忠，劉福生*.靶向聯(lián)合化療治療原發(fā)性中樞神經(jīng)系統(tǒng)淋巴瘤的研究.中華神經(jīng)醫(yī)學(xué)雜志.2014.13（1）.83-85.核心期刊

69. 周益強(qiáng)，金貴善 米蕊芳 董程遠(yuǎn) 張晉 劉福生*.血小板源性生長(zhǎng)因子B及其基因啟動(dòng)子區(qū)甲基化在腦膠質(zhì)瘤中的表達(dá)及意義.中華神經(jīng)外科雜志.2014.30(3).288-291.核心期刊

70. Peng Yan, Nana Zhao, Hao Hu, Xinyi Lin, Fusheng Liu, Fujian Xu*.A facile strategy to functionalize gold nanorods with polycation brushes for biomedical applications.Acta Biomater.2014.10（8）.3786-3794.SCI

71. 劉福生.努力提高腦膠質(zhì)瘤的診治水平.中華臨床醫(yī)師雜志.2013.7（14）.6217-6219.核心期刊

72. 聶秀濤，金貴善，米蕊芳，張國(guó)濱，謝堅(jiān)，曹澤，周益強(qiáng)，董程遠(yuǎn)，劉福生*.人腦膠質(zhì)瘤干細(xì)胞分化為血管內(nèi)皮細(xì)胞的實(shí)驗(yàn)研究.中華神經(jīng)外科雜志.2013.29（3）.289-293.核心期刊

73. 米蕊芳，劉福生，金貴善*.多核巨細(xì)胞對(duì)小鼠黑色素瘤細(xì)胞轉(zhuǎn)移能力的研究.中華臨床醫(yī)師雜志.2013.7(14).6457-6461.EI

74. Jin GS, Hao SY, Xie J, Mi RF and Liu FS*.Collision tumors of the sella: coexistence of pituitary adenoma and craniopharyngioma in the sellar region.World journal of surgical Oncology.2013.11.178（1-7）.SCI

75. 董程遠(yuǎn)，米蕊芳，劉福生*.TGF-beta/Smads 通路中信號(hào)轉(zhuǎn)導(dǎo)蛋白Smad2與Smad3的差異性研究進(jìn)展.中華臨床醫(yī)師雜志.2013.7（14）.6579-6581.核心期刊

76. 米蕊芳，劉福生，金貴善*.植物血凝素-ECM830細(xì)胞融合法融合黑色素瘤細(xì)胞.中國(guó)醫(yī)學(xué)科學(xué)院學(xué)報(bào).2013.35（5）.515-518.核心期刊

77. Jin GS, Zhou YQ, Chai Q, Zhu GD, Xu FJ, Liu FS*.VP22 and cytosine deaminase fusion gene modified tissue-engineered neural stem cells for glioma therapy.journal of cancer research and clinical oncology.2013.139.475-483.SCI

78. 曹澤，金貴善，劉福生*，謝堅(jiān).TGF-β2/Smad2 在人腦膠質(zhì)瘤組織中的表達(dá)及意義.中華臨床醫(yī)師雜志.2012.6（6）.43-46.核心期刊

79. 金貴善，劉福生*.培養(yǎng)科研型碩士研究生的科研思維.首都醫(yī)科大學(xué)學(xué)報(bào)社科版.2012.增刊.353-354.核心期刊

80. 劉福生，金貴善*.指導(dǎo)臨床醫(yī)學(xué)科研型碩士研究生發(fā)表SCI論文.首都醫(yī)科大學(xué)學(xué)報(bào)社科版.2012.增刊.355-357.核心期刊

81. Jin GS, Zhu GD, Zhao ZG, Liu FS* .VP22 enhances the expression of gluco-cerebrosidase in human Gauche II fibroblast cells mediated by lentivirus vector.Clinical and experimental medicine.2012.12.135-143.SCI

82. 謝堅(jiān)，李春德，劉福生*，陸睜，郭而安，張鵬飛，梁雄立，廖浩.經(jīng)腦外側(cè)裂切除島葉膠質(zhì)瘤.中華神經(jīng)外科雜志.2011.27（2）.208-209.核心期刊

83. 蘇偉，朱貴東，劉福生*，姜中利，金貴善，柴奇，曹澤，聶秀濤.Smad2基因在人腦膠質(zhì)瘤的表達(dá)及其臨床意義.中華神經(jīng)外科雜志.2011.27（10）.1064-1068.核心期刊

84. 張國(guó)濱，劉福生*、王忠誠(chéng).腦膠質(zhì)瘤干細(xì)胞巢的研究進(jìn)展.中華神經(jīng)外科雜志.2011.27（12）.1287-1290.核心期刊

85. 蘇偉，劉福生*，朱貴東，姜中利，金貴善，柴奇，曹澤.人腦膠質(zhì)瘤中轉(zhuǎn)化生長(zhǎng)因子β2、Smad3蛋白表達(dá)及臨床意義.中國(guó)康復(fù)理論與實(shí)踐.2011.17（5）.433-436.核心期刊

86. 朱貴東，劉福生*，蘇偉，金貴善，柴奇.內(nèi)皮抑素和血管生成抑素融合基因修飾的單純皰疹病毒對(duì)膠質(zhì)瘤干細(xì)胞的體外實(shí)驗(yàn)研究.中華神經(jīng)外科雜志.2011.27（9）.949-954.核心期刊

87. 蘇偉，劉福生*，姜中利.TGF-β/smads信號(hào)通路與膠質(zhì)瘤研究進(jìn)展.中華神經(jīng)外科雜志.2011.27（3）.322-324.核心期刊

88. Xu FJ, Zhu Y, Chai MY，Liu FS*.Comparison of ethanolamine/ethylenediamine-functionalized poly (glycidyl methacrylate) for efficient gene delivery.Acta Biomaterialia.2011.7.3131-3140.SCI

89. Zhu GD, Su W，Jin GS, Xu FJ, Hao SY, Guan FX, Jia W, Liu FS*.Glioma stem cells targeted by oncolytic virus carrying endostatin-angiostatin fusion gene and the expression of its exogenous gene in vitro.Brain Research.2011.1390.59-69.SCI

90. 朱貴東，劉福生*.溶瘤病毒治療腦膠質(zhì)瘤新進(jìn)展.中華神經(jīng)外科雜志.2010.26（5）.472-474.核心期刊

91. Xu FJ, Zhu Y, Liu FS，Nie J, Ma J, Yang WT.Comb-shaped conjugates comprising hydroxypropyl cellulose and low-molecular-weight poly (N-isopropylacryamide) side chains for smart hydrogeis: sythesis, characterization and biomedical applications..Bioconjugate Chemistry.2010.21(3).456-464.SCI

92. Xu FJ, Chai MY, Li WB, Ping Y, Tang GP, Yang WT, Ma J, Liu FS*.Well-defined poly (2-hydroxyl-3-(2-hydroxyethlamino) propyl methacylate) vectors with low cytotoxicity and high gene transfection efficiency.Biomacromolecules.2010.11(6).1437-1442.SCI

93. 金貴善, 劉福生* ,柴奇, 蘇偉 ,朱貴東.VP22修飾的CD基因工程化干細(xì)胞治療大鼠C6膠質(zhì)瘤體外膠質(zhì)瘤的研究.中華神經(jīng)外科雜志.2009.25(11).1039-1043.核心期刊

94. 金貴善，劉福生*，柴奇，蘇偉，朱貴東.慢病毒載體VP22-EGFP的構(gòu)建及其對(duì)大鼠神經(jīng)干細(xì)胞轉(zhuǎn)染及表達(dá)的研究.中華神經(jīng)外科雜志.2009.25.278-282.核心期刊

95. 王建交，李青松，詹奇，鄭永日，劉福生*.大鼠C6膠質(zhì)瘤模型構(gòu)建及生長(zhǎng)特性的研究.中國(guó)康復(fù)理論與實(shí)踐.2009.15（8）.742-744.核心期刊

96. 李遠(yuǎn)，焦紅亮，官方霞，宋來(lái)君，楊波，胡祥，杜英，李惠翔，龐霞，劉福生*，薛敬禮.人羊膜間充質(zhì)干細(xì)胞移植對(duì)荷瘤鼠C6膠質(zhì)瘤生長(zhǎng)的抑制.中國(guó)組織工程研究與臨床康復(fù).2008.12（51）.10099-10103.核心期刊

97. 王建交，楊立莊，劉福生* ，金貴善，柴奇.內(nèi)皮抑素和血管生成抑素融合基因的裂解病毒對(duì)C6膠質(zhì)瘤的實(shí)驗(yàn)研究.中華神經(jīng)外科雜志.2008.24（1）.69-72.核心期刊

98. Zhang Z, Jiang T, Xie J, Liu FS, Li SW, Qiao H, Wang ZC.Surgical strategies for glioma involving language areas..Chinese Medical Journal.2008.121(18).1800-1805.SCI

99. Jin GS, Liu FS*, Chai Q, Wang JJ, Li JH..Stable EGFP gene expression in C6 glioma cell line after transduction with HIV-based lentiviral vector.Chinese Journal of Cancer Research.2008.20.243-248.SCI

100. 金貴善，劉福生*，柴奇，王建交，車(chē)樹(shù)圣.慢病毒介導(dǎo)的穩(wěn)定表達(dá)綠色熒光蛋白的C6膠質(zhì)瘤細(xì)胞株的建立及其生物學(xué)特性的觀察.中華神經(jīng)外科雜志.2007.23.541-544.核心期刊

101. 車(chē)樹(shù)圣，孟慶海，金澎，李洛，劉福生*.腦膠質(zhì)瘤干細(xì)胞的體外培養(yǎng)與生物學(xué)特性的觀察.山東醫(yī)藥.2007.47（15）.1-2.核心期刊

102. Jin GS, Liu FS*, Chai Q, Li JH.Fusions of dendritic cells transfected with TGF-β1 antisense in treatment of intracranial gliomas..Chinese Journal of Cancer Research.2007.19.113-118.SCI

103. 劉福生*，歷俊華，林松，王忠誠(chéng).樹(shù)突狀細(xì)胞與反義TGF-β1基因修飾的膠質(zhì)瘤細(xì)胞融合瘤苗治療腦膠質(zhì)瘤的實(shí)驗(yàn)研究.中華神經(jīng)外科雜志.2006.22（1）.47-50.核心期刊

104. 姜中利，王忠誠(chéng)，江濤，劉福生*.顳葉內(nèi)側(cè)低級(jí)別膠質(zhì)瘤手術(shù)治療效果分析.山東大學(xué)學(xué)報(bào).2006.44（5）.481-483.核心期刊

105. 劉福生，王忠誠(chéng).神經(jīng)干細(xì)胞治療腦膠質(zhì)瘤的研究進(jìn)展.中華神經(jīng)外科雜志.2005.22（2）.123-126.核心期刊

106. 張建，張慶林，王成偉，于貽飛，郭華，孔建新，陶榮杰，劉福生*.膠質(zhì)瘤多藥耐藥細(xì)胞株大鼠動(dòng)物模型的建立及其生物學(xué)性質(zhì).中國(guó)醫(yī)學(xué)科學(xué)院學(xué)報(bào).2004.26 （1）.43-46.核心期刊

107. Liu Yuguang, Zhang Liangwen, Liu Fusheng, Zhu Shugan, Li Xingang, Su Wandong, Wu Chengyuan.Chronic expanding intracerebral hematoma.Journal of Clinical Neuroscience.2003.10(6).680–682.SCI

108. 劉福生，歷俊華，王忠誠(chéng).膠質(zhì)瘤免疫治療的新進(jìn)展.國(guó)外醫(yī)學(xué)免疫學(xué)分冊(cè).2003.26（1）.31-33.核心期刊

109. 劉福生，歷俊華，王忠誠(chéng).樹(shù)突狀細(xì)胞細(xì)胞株的研究進(jìn)展.國(guó)外醫(yī)學(xué)免疫學(xué)分冊(cè).2002.25（5）.279-282.核心期刊

110. 劉福生，王忠誠(chéng)，歷俊華，林松，任銘，肖慶，張亞卓.腫瘤抗原致敏樹(shù)突狀細(xì)胞瘤苗治療顱內(nèi)膠質(zhì)瘤的實(shí)驗(yàn)研究.中華神經(jīng)外科雜志.2002.18（2）.91-95.核心期刊

111. Chen Jianli, Jiang Sen, Yang Ruifang, Liu Fusheng, Sun Xiaoming.Mechanism of drug resistance and reversal with ligustra-zine and cyclosporina in cisplatin-induced human epithelial ovarian cancer resistant cell line 3Ao/cDDP..Chinese Journal of Cancer Research.2002.12(3).197-203.SCI

112. Liu Fusheng*, Wang Zhongcheng, Zhang Qinglin, Li Junhua, Zhang Yazhuo.Establishment of multidrug-resistance cell line C6/adr and reversal of drug resistance.Chinese Medical Journal.2002.115(2).238-241.SCI

113. 劉福生，張亞卓.樹(shù)突狀細(xì)胞與腫瘤的免疫治療策略.神經(jīng)疾病與精神衛(wèi)生.2001.1（1）.3-4.核心期刊

114. 劉福生，張慶林，趙麗，王成偉 ，金澎.膠質(zhì)瘤多藥耐藥機(jī)制的研究.中華外科雜志.2001.39（2）.172.核心期刊

115. 劉福生，張慶林.影響腦膠質(zhì)瘤化療效果的主要因素.山東醫(yī)藥.2001.41（7）.52-53.核心期刊

116. 劉福生，張慶林，卞繼峰，龐琦，王成偉.膠質(zhì)瘤多藥耐藥細(xì)胞系C6/adr的建立及其生物學(xué)特性的研究.中華神經(jīng)外科雜志.2001.17（2）.109-112.核心期刊

117. 劉福生，張慶林，趙麗，王成偉，金澎.腦膠質(zhì)瘤多藥耐藥細(xì)胞系C6/adr的建立及其耐藥性逆轉(zhuǎn)的研究.中華神經(jīng)外科雜志.2000.16（5）.320-323.核心期刊

118. 劉福生，張慶林，劉玉光，徐淑軍.慢性擴(kuò)張性腦內(nèi)血腫11例報(bào)告.山東醫(yī)科大學(xué)學(xué)報(bào).1999.37（2）.156-157.核心期刊

119. 劉福生，張慶林，劉玉光，徐淑軍.慢性擴(kuò)張性腦內(nèi)血腫.中華誤診學(xué)雜志.1998.1.48-49.核心期刊

120. 劉福生，魏東光，張慶林.HSV-tk /GCV系統(tǒng)基因治療顱內(nèi)惡性膠質(zhì)瘤的新進(jìn)展.中國(guó)腫瘤臨床與康復(fù).1998.5（5）.83-84.核心期刊

121. 劉福生，劉百波，丁曉東.顱腦損傷后你慢性腦腫脹18例分析.濰坊醫(yī)學(xué)院學(xué)報(bào).1996.18（3）. .核心期刊

122. 劉福生，張成，劉玉光，楊琳，張慶林.鼠腦內(nèi)注射rIL-2對(duì)腦組織和血腦屏障的影響.濰坊醫(yī)學(xué)院學(xué)報(bào).1995.17（3）.169-171.核心期刊

123. 劉福生，張文東，王在震，劉玉光.過(guò)繼性免疫治療顱內(nèi)轉(zhuǎn)移瘤1例.山東醫(yī)藥.1994.34（11）.62.核心期刊

124. 張文東，劉福生*.IL-2/LAK細(xì)胞療法在神經(jīng)外科的應(yīng)用.山東醫(yī)藥.1994.34（7）.45.核心期刊

125. 楊廷艦，王成偉，匡紹華，劉福生*.凹陷性骨折至竇匯損傷成功止血1例.濰坊醫(yī)學(xué)院學(xué)報(bào).1994.10（4）.266.核心期刊

126. 劉福生，王成偉，匡紹華，楊廷艦，唐衛(wèi)華.側(cè)腦室內(nèi)神經(jīng)節(jié)神經(jīng)瘤1例.濰坊醫(yī)學(xué)院學(xué)報(bào).1994.16（4）.262.核心期刊

127. 劉福生，劉玉光.三維CT血管造影診斷腦血管疾?。ㄗg文）.國(guó)外醫(yī)學(xué)神經(jīng)病學(xué)神經(jīng)外科學(xué)分冊(cè).1992.5.279.核心期刊

128. 劉福生，劉玉光.腦室引流與動(dòng)脈瘤再出血的關(guān)系（譯文）.國(guó)外醫(yī)學(xué)神經(jīng)病學(xué)神經(jīng)外科學(xué)分冊(cè).1992.5.280.核心期刊

主編或副主編的著作/譯著

1. 《腦膠質(zhì)瘤基礎(chǔ)與臨床研究》,主編,人民衛(wèi)生出版社,201603

2. 《腦膠質(zhì)瘤》,主編,人民衛(wèi)生出版社,200704

重要獎(jiǎng)項(xiàng)

1. 腦膠質(zhì)瘤化學(xué)治療和生物治療的研究 山東省科學(xué)技術(shù)進(jìn)步獎(jiǎng) 二等獎(jiǎng) 201312

2. 腦膠質(zhì)瘤化學(xué)治療和生物治療的實(shí)驗(yàn)研究 華夏醫(yī)學(xué)科技獎(jiǎng) 二等獎(jiǎng) 201208

3. 腦膠質(zhì)瘤化學(xué)治療和生物學(xué)治療的實(shí)驗(yàn)研究 山東高等學(xué)校優(yōu)秀科研成果獎(jiǎng) 一等獎(jiǎng) 201112

4. 腦膠質(zhì)瘤生物學(xué)特性及阻斷膠質(zhì)瘤耐藥基因的研究 中華醫(yī)學(xué)科技獎(jiǎng) 三等獎(jiǎng) 200712

5. 反義寡核苷酸阻斷腦膠質(zhì)瘤耐藥基因表達(dá)的實(shí)驗(yàn)研究 山東省科學(xué)技術(shù)獎(jiǎng)（自然科學(xué)獎(jiǎng)） 三等獎(jiǎng) 200704

6. 腦膠質(zhì)瘤生物學(xué)特性的實(shí)驗(yàn)研究 教育部提名的國(guó)家科技進(jìn)步獎(jiǎng) 二等獎(jiǎng) 200301

7. 腦膠質(zhì)瘤生物學(xué)特性的研究 山東省科學(xué)技術(shù)獎(jiǎng)（科技進(jìn)步獎(jiǎng)） 一等獎(jiǎng) 200209

8. 特殊類(lèi)型顱內(nèi)血腫的診斷與治療 山東省科學(xué)技術(shù)獎(jiǎng)（科技進(jìn)步獎(jiǎng)） 三等獎(jiǎng) 200209

9. 山東省十大科技成果獎(jiǎng) 山東省十大科技成果獎(jiǎng) 2002

10. 山東省優(yōu)秀博士畢業(yè)生 山東省優(yōu)秀博士畢業(yè)生 2000